Publications

Asterisks * indicate joint first authors

36: Retinal ganglion cell and microvascular density loss in hereditary spastic paraplegia.: Turski, G., Turski, C., Grobe-Einsler, M., Kobeleva, X., … & Klockgether, T. (2024).
Restorative Neurology and Neuroscience, in press. → DOI
35: Whole-brain modeling of the differential influences of amyloid-beta and tau in Alzheimer’s disease.: Patow, G., Stefanovski, L., Ritter, P., Deco, G., & Kobeleva, X. (for the Alzheimer’s Disease Neuroimaging Initiative) (2023).
Alzheimer's Research & Therapy, 15, 210. → DOI
34: Performance evaluation of automated white matter hyperintensity segmentation algorithms in a multicenter cohort on cognitive impairment and dementia.: Gaubert, M., Dell’Orco, A., … & DELCODE Study Group (Kobeleva, X. part of DECLODE Study Group) (2023).
Frontiers in Psychiatry, 13, 1010273. → DOI
33: Linking early-life bilingualism and cognitive advantage in older adulthood.: Ballarini, T., Kuhn, E., Röske, S., … Kobeleva, X., … & DELCODE Study Group (2023).
Neurobiology of Aging, 124, 18-28. → DOI
32: Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers.: Jessen, F., Wolfsgruber, S., Kleineindam, L., … Kobeleva, X., … & Düzel, E. (2023).
Alzheimer's & Dementia, 19(2), 487-497. → DOI
31: Midlife occupational cognitive requirements protect cognitive function in old age by increasing cognitive reserve.: Kleineidam, L., Wolfsgruber, S., Weyrauch, A.-S., … Kobeleva, X., … & Wagner, M. (2022).
Frontiers in Psychology, 13, 957308. → DOI
30: Coherent structural and functional network changes after Nucleus Ventralis Intermedius lesion in Essential Tremor.: Pohl, E.*, Upadhuay, N.*, Kobeleva, X.*, … & Boecker, H. (2022).
Movement Disorders, 37(9), 1924-1929. → DOI
29: Advancing brain network models to reconcile functional neuroimaging and clinical research.: Kobeleva, X., Varoquaux, G., Dagher A., Adhikari, M., Grefkes, C., Gilson, M. (2022).
NeuroImage Clinical, 36, 103262. → DOI
28: Adult-Onset Neurodegeneration in Nucleotide Excision Repair Disorders (NERD_ND): Time to Move Beyond the Skin.: Cordts, E., Oender, D., Traschütz, A., Kobeleva, X., … & Deschauer, M. (2022).
Movement Disorders, 37(8), 1707-1718. → DOI
27: Revealing the relevant spatiotemporal scale underlying whole-brain dynamics.: Kobeleva, X., López-González, A., Kringelbach, M., & Deco, G. (2021).
Frontiers in Neuroscience, 15, 715861. → DOI
26: Brain activity is contingent on neuropsychological function in an fMRI study of Verbal Working Memory in Amyotrophic Lateral Sclerosis.: Kobeleva, X., Machts, J., Veit, M., Vielhaber, S., Petri, S., & Schoenfeld, M.A. (2021).
European Journal of Neurology, 28(89), 3051-3060. → DOI
25: Clinically applicable quantitative magnetic resonance morphologic measurements of grey matter changes in the human brain.: Fu, T., Kobeleva, X., Bronzlik, P., Nösel, P., Dadak, M., Lanfermann, H., Petri, S., Ding X. (2021).
Brain Sciences, 11(1), 55. → DOI
24: Brainhack: Developing a culture of open, inclusive, community-driven neuroscience.: Gau, R., Noble, S., …, Kobeleva, X., … & The Brainhack Community (2021).
Neuron, 109(11), 1769-1775. → DOI
23: Centering inclusivity in the design of online conferences—An OHBM–Open Science perspective.: Levitis, E., van Praag, CDG, …, Kobeleva, X., … & Maumet, C. (2021).
GigaScience, 10(8), giab051. → DOI
22: Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers—results from the DELCODE study.: Sannemann, L., Schild, A.-K., … Kobeleva, X., … & Jessen, F. (2020).
Alzheimer's Research & Therapy, 12(1), 1-11. → DOI
21: Minor neuropsychological deficits in patients with subjective cognitive decline.: Wolfsgruber, S., Kleineidam L., … & DELCODE Study Group (Kobeleva, X. part of DECLODE Study Group) (2020).
Neurology, 95(9), e1134-e1143. → DOI
20: Bi-allelic HPDL variants cause a neurodegenerative disease ranging from Neonatal Encephalopathy to Adolescent-Onset Spastic Paraplegia.: Husain, R.A., Grimmel, A., … Kobeleva, X., … Haack, T.B. (2020).
American Journal of Human Genetics, 107(2), 364-373. → DOI
19: Truncating Mutations in UBAP1 Cause Hereditary Spastic Paraplegia.: Fard, M. A. F., Rebelo, A. P., Buglo, E., Nemati, H., Dastsooz, H., Gehweiler, I., … Kobeleva, X., … & Cortese, A. (2019).
The American Journal of Human Genetics, 104(4), 767-773. → DOI
18: Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.: Ludolph, A. C., Schuster, … & RAS-ALS Study Group (Kobeleva, X. part of RAS-ALS Study Group) (2018).
The Lancet Neurology, 17(8), 681-688. → DOI
17: Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.: Westeneng, H. J., Debray, T. P., Visser, A. E., van Eijk, R. P., Rooney, J. P., Calvo, A., … Kobeleva, X., … & van den Berg, L. H. (2018).
The Lancet Neurology, 17(5), 423-433. → DOI
16: Electroencephalographic derived network differences in Lewy body dementia compared to Alzheimer’s disease patients.: Peraza, L. R., Cromarty, R., Kobeleva, X., Firbank, M. J., Killen, A., Graziadio, S., … & Taylor, J.-P. (2018).
Scientific Reports, 8(1), 4637. → DOI
15: Divergent functional connectivity during attentional processing in Lewy body dementia and Alzheimer’s disease.: Kobeleva, X.*, Firbank, M.*, Peraza, L., Gallagher, P., Thomas, A., Burn, D. J., … & Taylor, J. P. (2017).
Cortex, 92, 8-18. → DOI
14: Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial.: Meininger, V., Genge, A., … & NOG112264 Study Group (Kobeleva, X. part of NOG112264 Study Group) (2017).
The Lancet Neurology, 16(3), 208-216. → DOI
13: Forschung für Alle in der Junge-Neurologen-Postersession (in German language).: Kobeleva, X. (2017).
NeuroTransmitter, S1/2017, 54. → DOI
12: Working memory network changes in ALS: an fMRI Study.: Vellage, A. K., Veit, M., Kobeleva, X., Petri, S., Vielhaber, S., & Müller, N. G. (2016).
Frontiers in Neuroscience, 10, 158. → DOI
11: Neural correlates of attention‐executive dysfunction in lewy body dementia and Alzheimer’s disease.: Firbank, M.*, Kobeleva, X.*, Cherry, G., Killen, A., Gallagher, P., Burn, D. J., … & Taylor, J. P. (2016).
Human Brain Mapping, 37(3), 1254-1270. → DOI
10: Hilfsmittelversorgung bei der amyotrophen Lateralsklerose (in German language).: Funke, A., Grehl, T., Großkreutz, J., Münch, C., Walter, B., Kettemann, D., … Kobeleva, X., … & Meyer, T. (2015).
Der Nervenarzt, 86(8), 1007-1017. → DOI
9: International Issues: An international survey of young neurologists’ perceptions of future health care and neurology.: Macerollo, A., Róna-Vörös, K., Struhal, W., Kobeleva, X., & Sellner, J. (2015).
Neurology, 84(4), e20-e23. → DOI
8: Dissociation of explicit and implicit measures of the behavioral inhibition and activation system in borderline personality disorder.: Kobeleva, X., Seidel, E. M., Kohler, C., Schneider, F., Habel, U., & Derntl, B. (2014).
Psychiatry Research, 218(1-2), 134-142. → DOI
7: International Issues: Cross-border mobility of junior neurologists within and to the European Union.: Macerollo, A., Varga, E. T., Struhal, W., Györfi, O., Kobeleva, X., & Sellner, J. (2014).
Neurology, 83(13), e128-e131. → DOI
6: Varicella zoster-associated retinal and central nervous system vasculitis in a patient with multiple sclerosis treated with natalizumab.: Kobeleva, X., Wegner, F., Brunotte, I., Dadak, M., Dengler, R., & Stangel, M. (2014).
Journal of Neuroinflammation, 11(1), 19. → DOI
5: DGN-Kongress 2013. Wo muss ich hin? – Medizin für kluge Köpfe (in German language).: Ossig, C., Kobeleva, X., Wilcken, S., Müller, L., Bernhard, F., & Angermaier, A. (2013).
NeuroTransmitter, S1/2013, 50-52. → DOI
4: The European Association of Young Neurologists and Trainees in 2013: striking a blow for European junior neurologists.: Macerollo, A., Varga, E. T., Györfi, O., Kobeleva, X., Paterson, R. W., & Sellner, J. (2013).
European Journal of Neurology, 20(4), e54-e58. → DOI
3: Barriers to novel therapeutics in amyotrophic lateral sclerosis.: Kobeleva, X., & Petri, S. (2013).
Neurodegenerative Disease Management, 3(6), 525-537. → DOI
2: E-learning preferences of European junior neurologists—an EAYNT survey.: Sztriha, L. K., Varga, E. T., Róna-Vörös, K., Holler, N., Ilea, R., Kobeleva, X., … & Sellner, J. (2012).
Frontiers in Neurology, 3, 167. → DOI
1: Nachwuchsarbeit 2011 auf nationaler und europäischer Ebene: Die Aktivitäten der Jungen Neurologen und der EAYNT (in German language).: Holler, N., Kobeleva, X., Hilienhof, A., Wolz, M., & Sellner, J. (2011).
Aktuelle Neurologie, 38(01), 45-47. → DOI

‹ Go back to the team page Go to our secion with non-technical information ›